James R. Gavin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
James R. Gavin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Ahmann
Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Science University, Portland, OR
1 shared publication - Antonio Ceriello
IRCCS Multimedica, Milan, Italy
1 shared publication - Christopher G. Parkin
CGParkin Communications, Inc., Henderson, NV, USA
1 shared publication - Davida F. Kruger
Division of Endocrinology, Diabetes, Bone and Mineral Disease, Henry Ford Health System, Detroit, Michigan
1 shared publication - Dennis R Harris
Endocrine Society, Washington, District of Columbia
1 shared publication - Eberhard Standl
Forschergruppe Diabetes E.V. at the Helmholtz Center, Munich, Neuherberg, Germany
1 shared publication
Latest Publications
- Open Access
- 14 November 2018
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 2 (12) , 1320-1337
Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals with diabetes. CGM systems provide retrospective data, as well as the current glucose value and trend arrow data, which indicate the direction and velocity of changing glucose. In 2017, Aleppo and colleagues developed a simplified approach for adults with diabetes to safely adjust rapid-acting insulin doses using trend arrow information in the Dexcom G5 CGM system. Since that time, the FreeStyle Libre and FreeStyle Libre 14 day CGM systems have become available in the United States; however, guidance on using trend arrow data that take the unique features of these systems into consideration is lacking. Specifically, the FreeStyle Libre systems do not have automatic alarms, which impact how the system and trend arrow data are used. Endocrine Society convened an expert panel to address this gap and develop an approach to adjusting rapid-acting insulin doses for adults using trend arrows in the FreeStyle Libre systems. We based our approach on previous work and expanded upon engagement and scanning recommendations as well as incorporate pre-exercise planning specific to these systems. Our approach provides insulin dose adjustments as discrete insulin units based on an individual’s insulin sensitivity and directionality of the trend arrow. We focus on the needs of patients treated by multiple daily injection because these individuals currently make up a greater proportion of individuals on intensive insulin therapy. Our recommendations are intended to provide a safe, practical approach to using trend arrows in the FreeStyle Libre systems.
- 14 November 2018
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 2 (12) , 1320-1337
Open AccessApproach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
The use of personal continuous glucose monitoring (CGM) has expanded dramatically among individuals with diabetes. CGM systems provide retrospective data, as well as the current glucose value and trend arrow data, which indicate the direction and velocity of changing glucose. In 2017, Aleppo and colleagues developed a simplified approach for adults with diabetes to safely adjust rapid-acting insulin doses using trend arrow information in the Dexcom G5 CGM system. Since that time, the FreeStyle Libre and FreeStyle Libre 14 day CGM systems have become available in the United States; however, guidance on using trend arrow data that take the unique features of these systems into consideration is lacking. Specifically, the FreeStyle Libre systems do not have automatic alarms, which impact how the system and trend arrow data are used. Endocrine Society convened an expert panel to address this gap and develop an approach to adjusting rapid-acting insulin doses for adults using trend arrows in the FreeStyle Libre systems. We based our approach on previous work and expanded upon engagement and scanning recommendations as well as incorporate pre-exercise planning specific to these systems. Our approach provides insulin dose adjustments as discrete insulin units based on an individual’s insulin sensitivity and directionality of the trend arrow. We focus on the needs of patients treated by multiple daily injection because these individuals currently make up a greater proportion of individuals on intensive insulin therapy. Our recommendations are intended to provide a safe, practical approach to using trend arrows in the FreeStyle Libre systems.
- Open Access
- 1 January 2007
- Published by Touch Medical Media, Ltd. in US Endocrinology
- Vol. 00 (02) , 42
The Importance of Monitoring Blood Glucose
It is estimated that diabetes, both type 1 and type 2, currently affects more than 195 million people worldwide. This figure is expected to rise to more than 330 million by 2030.1,2 The rise in type 1 diabetes has been linked to changing environmental factors,3 while the rise in type 2 diabetes is strongly associated with increasing rates of obesity.4
- 1 January 2007
- Published by Touch Medical Media, Ltd. in US Endocrinology
- Vol. 00 (02) , 42
Open AccessThe Importance of Monitoring Blood Glucose
It is estimated that diabetes, both type 1 and type 2, currently affects more than 195 million people worldwide. This figure is expected to rise to more than 330 million by 2030.1,2 The rise in type 1 diabetes has been linked to changing environmental factors,3 while the rise in type 2 diabetes is strongly associated with increasing rates of obesity.4